NASDAQ:BCRX

Biocryst Pharmaceuticals Stock News

etoro logo Buy BCRX
*Your capital is at risk
$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
BioCryst Pharmaceuticals Inc:
Gilead sinks 6% to $76.28 after FT says remdesivir failed in first trial GILD
Gilead's remdesivir disappoints in first clinical trial, FT reports GILD
Markets move lower after FT report of failed Gilead COVID-19 trial SPX SPY GILD
Treasury announced a $120 B 3-pronged package of shorter coupon auctions
UniCredit price target lowered to EUR 8.50 from EUR 16 at Deutsche Bank Deutsche Bank UNCRY
Intesa Sanpaolo price target lowered to EUR 1.70 from EUR 3 at Deutsche Bank Deutsche Bank ISNPY
Mediobanca price target lowered to EUR 7.50 from EUR 11.80 at Deutsche Bank Deutsche Bank MDIBY
Banco de Sabadell price target lowered to EUR 0.55 at Deutsche Bank Deutsche Bank BNDSF
Banco Santander price target lowered to EUR 2.98 from EUR 3.90 at Deutsche Bank Deutsche Bank SAN
BBVA price target lowered to EUR 4.05 from EUR 5.60 at Deutsche Bank Deutsche Bank BBVA
Bankia price target lowered to EUR 1.34 from EUR 2 at Deutsche Bank Deutsche Bank BNKXF
Bankinter price target lowered to EUR 5.10 from EUR 6.80 at Deutsche Bank Deutsche Bank BKIMF
CaixaBank price target lowered to EUR 2.67 from EUR 3.25 at Deutsche Bank Deutsche Bank CAIXY
KBC Group price target lowered to EUR 51 from EUR 73 at Deutsche Bank Deutsche Bank KBCSY
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE